Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pd-1 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06643533
What this trial is testing

Fecal Microbiota Transplantation in Reversing Drug Resistance in Unresectable HCC (TALENP004)

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Fujian Provincial Hospital 15
Testing effectiveness (Phase 2)Study completedNCT03554473
What this trial is testing

M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers

Who this might be right for
Carcinoma, Small CellLung CancerSmall Cell Lung Cancer
National Cancer Institute (NCI) 37
Early research (Phase 1)UnknownNCT06045286
What this trial is testing

High- and Low-dose Radiotherapy Combined With PD-1 Inhibitors for MSS CRLM

Who this might be right for
Colorectal Liver Metastases
Jiangsu Cancer Institute & Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06826079
What this trial is testing

Safety and Efficacy Study of Sorbitol With Neoadjuvant Chemotherapy Combined With Tirellizumab (PD-1 Inhibitor) in Patients With Locally Advanced Gastric Cancer

Who this might be right for
Gastric Junction AdenocarcinomaGastric CancerImmunotherapy+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 86
Testing effectiveness (Phase 2)UnknownNCT04769076
What this trial is testing

The Paclitaxel (Albumin-bound) Combined With Cisplatin, PD-1 Inhibitors and IMRT in the Treatment of Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 40
Testing effectiveness (Phase 2)Looking for participantsNCT07030140
What this trial is testing

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

Who this might be right for
CholangiocarcinomaHilar CholangiocarcinomaBile Duct Cancer
Jinbo Yue 38
Testing effectiveness (Phase 2)Looking for participantsNCT06084897
What this trial is testing

Radiotherapy in Patients With Metastatic Esophageal Cancer Responding to PD-1 Inhibitor Plus Chemotherapy

Who this might be right for
Esophageal Neoplasm MetastaticEsophageal Cancer Stage IVb
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06858969
What this trial is testing

Chidamide in Combination With PD-1 Inhibitor, Bevacizumab, and XELOX for Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 130
Testing effectiveness (Phase 2)UnknownNCT04611711
What this trial is testing

Phase I/II Clinical Study of Decitabine Combined With TQB2450 Injection or Decitabine + Anlotinib Combined With TQB2450 Injection in the Treatment of PD-1 Monoclonal Antibody-resistant Digestive System Tumors

Who this might be right for
Patients With Digestive System Tumors Resistant to PD-1 Inhibitors
Peking University 60
Testing effectiveness (Phase 2)Looking for participantsNCT07518979
What this trial is testing

EGFR-ADC (Becotatug Vedotin) Combined With PD-1 Inhibitor (Pucotenlimab) in Neoadjuvant Treatment of Advanced Penile Cancer

Who this might be right for
Penile Cancer
Jiyan Liu 60
Testing effectiveness (Phase 2)Looking for participantsNCT06992362
What this trial is testing

Perioperative Treatment of Hepatoid Adenocarcinoma of Stomach

Who this might be right for
Hepatoid Adenocarcinoma of Stomach
Peking University Cancer Hospital & Institute 30
Not applicableLooking for participantsNCT07337096
What this trial is testing

Electro-Acupuncture in Lung cancER : EALER Study

Who this might be right for
Non Small Cell Lung CancerAccupuncturePD-1 Inhibitors
Guangzhou University of Traditional Chinese Medicine 424
Early research (Phase 1)UnknownNCT04193098
What this trial is testing

Study of Autologous Cytotoxic T Lymphocyte Immunotherapy Combination With PD-1 Inhibitor in the Advanced NSCLC

Who this might be right for
Non-small Cell Lung CancerSecond-line Treatment
Tianjin Medical University Cancer Institute and Hospital 10
Large-scale testing (Phase 3)Looking for participantsNCT06627712
What this trial is testing

SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC

Who this might be right for
TNBC - Triple-Negative Breast Cancer
West China Hospital 318
Testing effectiveness (Phase 2)Looking for participantsNCT07489989
What this trial is testing

Enhancing CAR-T Cell Therapy Efficacy in B-cell Lymphoma Via Chidamide and PD-1 Inhibitor Combination.

Who this might be right for
Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
Daihong Liu 30
Testing effectiveness (Phase 2)Temporarily pausedNCT07057089
What this trial is testing

Involved-field Radiotherapy-TNT Combined With PD-1 Inhibitor for pMMR Locally Advanced Rectal Cancer (Neo-Field I)

Who this might be right for
Locally Advanced Rectal Cancer
Hebei Medical University Fourth Hospital 90
Very early researchUnknownNCT04046185
What this trial is testing

Programmed Death-1(PD-1) Inhibitor Combined With Progesterone Treatment in Endometrial Cancer

Who this might be right for
Endometrial Cancer Stage I
Shanghai First Maternity and Infant Hospital 60
Not applicableUnknownNCT05638425
What this trial is testing

Radiotherapy Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of NSCLC Patients With Symptomatic Brain Metastases

Who this might be right for
Non-small Cell Lung Cancer MetastaticBrain Metastases
Xiangya Hospital of Central South University 20
Testing effectiveness (Phase 2)Looking for participantsNCT04375384
What this trial is testing

Cetuximab After Immunotherapy for the Treatment of Head and Neck Squamous Cell Cancer

Who this might be right for
Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell CarcinomaMetastatic Head-and-neck Squamous-cell Carcinoma
Wake Forest University Health Sciences 38
Not applicableLooking for participantsNCT07485114
What this trial is testing

Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors

Who this might be right for
Renal Cell Carcinoma (Kidney Cancer)Non Small Cell Lung CancerHepatocellular Carcinoma+1 more
Daniel Keizman 300
Next Page